Magnesium-containing oxytocin formulations and methods of use

• 收藏
• 分享

专利权人:

Inc.;Trigemina

发明人:

Carson, Dean,Yeomans, David C.

申请号：

AU2017250505

公开号：

AU2017250505A1

申请日:

2017.04.12

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

Disclosed are methods and compositions for the treatment of autism spectrum disorder, related disorders and symptoms of such disorders, comprising co-administration of an oxytocin peptide and magnesium ions. Co-administration of an oxytocin peptide and magnesium ions results in a synergistic or enhanced effect on reducing social and communication deficits in a patient suffering from an autism spectrum disorder.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/